Clinical trials: Liver Biopsy
Virus Disease
Collection of Liver Tissue for Virologic Studies
This study will examine liver tissue to investigate the role of viral infections in fulminant hepatitis, liver failure, and profound bone marrow failure.
- Trial name
- NCT00005936
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Liver Neoplasms
A New Track Ablation Device for Liver Biopsy: A Feasibility Study
The purpose of this study is to evaluate the effectiveness and safety of a new biopsy track ablation device for liver biopsy.
- Trial name
- NCT02521129
- Testing
- Biopsy Track Ablator (STARmed, Goyang, Korea)
- Volunteers
- 20 people
- Sponsor
- Samsung Medical Center
Cancer, Lung, Cancer, Breast
Early Detection of Five Common Cancers Using the ctDNA Analysing Test
This is a multi-centre, prospective cohort study, aiming to evaluate a blood test in early detection of the four common cancers, based on the investigation of the circulating tumour DNA (ctDNA).
- Conditions
- Cancer, Lung, Cancer, Breast, Cancer Liver, Cancer, Colorectal
- Trial name
- K-DETEK (NCT05227261)
- Where
- Vietnam
- Volunteers
- 9,057 people, healthy volunteers welcome
- Sponsor
- Gene Solutions
PDAC - Pancreatic Ductal Adenocarcinoma
Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting
Early liver metastasis (Early-LiM) is the most significant prognostic factor in pancreatic ductal adenocarcinoma (PDAC) and is thought to originate from occult micrometastases present at the time of surgery.
- Trial name
- FORESIGHT (NCT07224802)
- Testing
- EXELiM assay (qRT-PCR validation), EXELiM small RNA sequencing
- Where
- United States
- Volunteers
- 372 people
- Sponsor
- City of Hope Medical Center
Fatty Liver, Hepatic Steatosis
Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis
This will be a multi-center, prospective, controlled study. It is expected that about 240 subjects from 10 study centers will be enrolled, and 224 effective subjects will be statistically analyzed in the end, in which 56…
- Conditions
- Fatty Liver, Hepatic Steatosis, Liver Steatosis
- Trial name
- NCT02456766
- Testing
- FibroTouch, Liver Biopsy
- Where
- 8 sites in China
- Volunteers
- 240 people
- Sponsor
- Wuxi Hisky Medical Technology Co Ltd
Liver Transplants
Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry
The goal is to have a small spectrometer (pocket size) , reliable and rapid tool that can be used during liver harvesting, which enables macrosteatosis to be evaluated reproducibly and selectively, at any time.
- Trial name
- iGRAISSE (NCT05106322)
- Testing
- intraoperative spectrometer scan
- Where
- 3 sites in France
- Volunteers
- 240 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis (MASH) and compensated…
- Trial name
- NCT06920043
- Testing
- Efimosfermin
- Where
- 30 sites in United States
- Volunteers
- 42 people
- Sponsor
- GlaxoSmithKline
Carcinoma, Hepatocellular, Hepatocellular Cancer
Vascular Invasion Prediction Via a Multimodal Model Supports Re-staging of Early-stage Hepatocellular Carcinoma
Effective strategies for personalized treatment decisions for early-stage hepatocellular carcinoma (HCC) remain critically limited. Microvascular invasion (MVI) is a distinctive pathological hallmark of HCC invasiveness.
- Conditions
- Carcinoma, Hepatocellular, Hepatocellular Cancer, Liver Cancer
- Trial name
- NCT05540925
- Testing
- Curative-intent liver resection
- Where
- China
- Volunteers
- 3,650 people
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
NASH - Nonalcoholic Steatohepatitis
Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)
This study will assess the effect of 3 doses of PXL065 versus placebo on liver fat content in NASH patients after 36 weeks of treatment
- Trial name
- NCT04321343
- Testing
- PXL065
- Where
- 29 sites in United States
- Volunteers
- 117 people
- Sponsor
- Poxel SA
Hepatocellular Carcinoma
An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC
This study is aimed to establish an organoid-on-chips technological system based on biopsy samples and evaluate its efficacy in predicting the response to mFOLFOX6 infusion in patients with hepatocellular carcinoma (HCC).
- Trial name
- NCT05932836
- Testing
- No interventions.
- Where
- China
- Volunteers
- 226 people
- Sponsor
- Xiangya Hospital of Central South University
Intrahepatic Cholangiocarcinoma (Icc)
Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.
Occult metastasis at the time of surgery is a major driver of poor outcomes in intrahepatic cholangiocarcinoma (ICC), yet reliable preoperative biomarkers to identify such patients are lacking.
- Trial name
- EXOMIC (NCT07224737)
- Testing
- EXOMIC small RNA sequencing, EXOMIC assay (qRT-PCR validation)
- Where
- United States
- Volunteers
- 230 people
- Sponsor
- City of Hope Medical Center
Hepatocellular Carcinoma
Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective Study
This study aims to develop a novel, reliable, liquid biopsy-based biomarker system for relapse of HCC associated with hepatitis B after liver transplantation.
- Trial name
- NCT03708705
- Testing
- Risk model of tumor relapse
- Volunteers
- 500 people
- Sponsor
- Zhejiang University
HBV (Hepatitis B Virus), Hepatitis B
Lamivudine and Adefovir to Treat Chronic Hepatitis B
This study will evaluate the safety and effectiveness of lamivudine plus adefovir versus adefovir alone to treat chronic hepatitis B infection.
- Conditions
- HBV (Hepatitis B Virus), Hepatitis B, Hepatitis
- Trial name
- NCT00023309
- Testing
- Lamivudine and adefovir, Adefovir alone
- Where
- United States
- Volunteers
- 41 people
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NASH - Nonalcoholic Steatohepatitis
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH
The study includes 52 weeks, double-blind treatment period. Clinic visits will occur at Randomization and every four weeks from Week 4 through Week 52 and through End of Study period.
- Trial name
- VOYAGE (NCT04173065)
- Testing
- VK2809
- Where
- 79 sites in United States, Belgium and 3 more
- Volunteers
- 248 people
- Sponsor
- Viking Therapeutics, Inc.
Liver Biopsy
Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion
A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment.
- Trial name
- NCT00643656
- Testing
- Kalinox 170 bar, Mix of 50% oxygen and 50% nitrogen
- Where
- France
- Volunteers
- 94 people
- Sponsor
- Air Liquide Santé International
Hepatic Cancer, Hepatic Neoplasm
Endoscopic Ultrasound Guided Liver Biopsy
This is a prospective study to determine the optimal technique for obtaining liver tissue with a smaller caliber (22 gauge) needle and whether a good core biopsy can be obtained without the use of suction and secondly to…
- Conditions
- Hepatic Cancer, Hepatic Neoplasm, Hepatic Carcinoma
- Trial name
- NCT03307811
- Testing
- 22 gauge needle liver biopsy
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- AdventHealth
Non-Alcoholic Fatty Liver Disease
Plant Sterols and Plant Stanols and Liver Inflammation
As the prevalence of obesity is reaching epidemic proportions, the prevalence of non-alcoholic fatty liver disease (NAFLD), including non-alcoholic steatohepatitis (NASH), increases concomitantly and becomes a major global health…
- Trial name
- NCT03627819
- Testing
- Plant sterol-enriched margarine, Plant stanol-enriched margarine, Control margarine
- Where
- Netherlands
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Maastricht University Medical Center
NAFLD, NASH
Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy
This study is to assess the diagnostic performance of the LiverFASt Test for assessing fibrosis staging scores compared to the assessment of liver tissue pathology from liver biopsy.
- Trial name
- NCT03980912
- Testing
- LiverFASt
- Where
- United States
- Sponsor
- Fibronostics USA, Inc
Non-Alcoholic Fatty Liver Disease, Steatohepatitis, Nonalcoholic
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent condition, and when fatty liver is associated with inflammation and hepatocellular injury (steatohepatitis), it can lead to fibrosis, cirrhosis, liver failure and…
- Conditions
- Non-Alcoholic Fatty Liver Disease, Steatohepatitis, Nonalcoholic, Liver Fibroses
- Trial name
- ImagingNAFLD (NCT04785937)
- Testing
- Ultrasound and Magnetic Resonance
- Where
- Italy
- Volunteers
- 28 people
- Sponsor
- Azienda USL Reggio Emilia - IRCCS
Liver Cirrhosis, Liver Disease Chronic
Assessing EUS and Percutaneous Untargeted Liver Biopsy Quality
This prospective, single-center study evaluates and compares the tissue sample quality and patient comfort of different liver biopsy methods.
- Conditions
- Liver Cirrhosis, Liver Disease Chronic, Liver Transplant
- Trial name
- EUS-PERC (NCT07701031)
- Testing
- EUS Liver biopsy 19G FNA, EUS LB 19G FNB, EUS LB 22G FNB
- Where
- Germany
- Volunteers
- 146 people
- Sponsor
- University Hospital Muenster